Cancer Targeting Potential of 99mTc-Finasteride in Experimental Model of Prostate Carcinogenesis-Reference-Cited by-同舟云学术

Cancer Targeting Potential of 99mTc-Finasteride in Experimental Model of Prostate Carcinogenesis

Published:2017-03 Issue:2 Volume:32 Page:39-47
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Jan Gowsia¹,Passi Neelima D.²,Dhawan Devinder Kumar³,Chadha Vijayta Dani¹

Affiliation:

1. Center for Nuclear Medicine (UIEAST), Panjab University, Chandigarh, India.

2. University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh, India.

3. Department of Biophysics, Panjab University, Chandigarh, India.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2016.2032

Reference32 articles.

1. American Cancer Society. Cancer Facts & Figures 2016. Atlanta, GA: American Cancer Society, 2016.

2. Imaging Prostate Cancer: A Multidisciplinary Perspective

3. Use of [11C]Choline PET-CT as a Noninvasive Method for Detecting Pelvic Lymph Node Status from Prostate Cancer and Relationship with Choline Kinase Expression

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Target specific uptake of a newly synthesized radiolabeled 5α-reductase inhibitor “Tc-99m-17-Oxo-17a-Aza-D-Homo-5-Androsten-3β-yl phenoxyacetate (Tc-99m-17a-Aza Steroid)” in rat prostatic neoplastic lesions;Indian Journal of Nuclear Medicine;2022

2. ^99mTc LABELED N-ACETYL NEURAMINIC ACID AS A NEW RADIONUCLIDE PROBE FOR TARGETING CANCER: IN-SILICO AND IN-VITRO STUDY;INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH;2020-03-01

3. Development and initial characterization of 99mTc labeled N-acetyl neuraminic acid for its application in in-vivo imaging of cancer: a preclinical study;Journal of Radioanalytical and Nuclear Chemistry;2019-09-26

4. Targeting 5α-reductase with 99mTc labeled dutasteride derivatives for prostate imaging;Radiochimica Acta;2019-09-13